Edesa Biotech Ownership | Who Owns Edesa Biotech?

Edesa Biotech Ownership Summary

Edesa Biotech is owned by 41.48% institutional investors, 17.06% insiders, and 41.46% retail investors. Velan capital investment management lp is the largest institutional shareholder, holding 9.79% of EDSA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.44% of its assets in Edesa Biotech shares.

EDSA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Edesa Biotech	41.48%	17.06%	41.46%
Sector	Healthcare Stocks	232.20%	10.74%	-142.94%
Industry	Biotech Stocks	382.11%	10.55%	-292.66%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Velan capital investment management lp	687.50K	9.79%	$1.70M
Stonepine capital management	687.50K	9.79%	$1.70M
Rubric capital management lp	687.50K	9.74%	$976.25K
Nantahala capital management	625.00K	8.85%	$887.50K
Drw securities	134.22K	1.90%	$190.59K
Geode capital management	46.54K	0.82%	$67.48K
Vanguard group	37.60K	0.53%	$54.52K
Morgan stanley	2.30K	0.03%	$3.27K
Royal bank of canada	1.82K	0.03%	$4.00K
Ubs group	1.36K	0.02%	$1.93K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Velan capital investment management lp	687.50K	1.59%	$1.70M
Stonepine capital management	687.50K	1.38%	$1.70M
Nantahala capital management	625.00K	0.03%	$887.50K
Rubric capital management lp	687.50K	0.01%	$976.25K
Drw securities	134.22K	0.01%	$190.59K
Tower research capital llc (trc)	1.28K	0.00%	$3.16K
Cibc world market	-	-	-
Renaissance	-	-	-
Fifth third bancorp	-	-	-
Barclays	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Stonepine capital management	687.50K	1.38%	687.50K
Drw securities	134.22K	0.01%	134.22K
Morgan stanley	2.30K	-	2.30K
Geode capital management	46.54K	-	1.30K
Global retirement partners	86.00	-	61.00

Top Sellers

Holder	Shares	% Assets	Change
Commonwealth equity services	-	-	-37.55K
Renaissance	-	-	-25.00K
Cibc world market	-	-	-20.00K
Vanguard group	37.60K	-	-7.94K
Citigroup	-	-	-2.00K

New Positions

Holder	Shares	% Assets	Change	Value
Drw securities	134.22K	0.01%	134.22K	$190.59K

Sold Out

Holder	Change
Barclays	-6.00
Raymond james financial	-29.00
Fifth third bancorp	-100.00
Citigroup	-2.00K
Cibc world market	-20.00K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	15	-34.78%	2,928,431	1.80%	41	2.47%	5	-44.44%	2	-33.33%
Sep 30, 2025	22	15.79%	2,876,708	36.46%	40	2.59%	10	25.00%	3	50.00%
Jun 30, 2025	19	5.56%	2,108,116	-25.30%	39	1.40%	8	-	2	-33.33%
Mar 31, 2025	18	12.50%	2,822,206	1260.01%	53	138.22%	8	33.33%	3	50.00%
Dec 31, 2024	16	-5.88%	207,513	28.61%	6	24.36%	6	50.00%	2	100.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Institutional Extnd Mkt Idx Tr	37.14K	0.44%	-
Fidelity Extended Market Index	31.61K	0.38%	1.30K
DFA US Micro Cap I	7.91K	0.11%	-
DFA US Core Equity 2 I	3.42K	0.10%	-
Spartan Extended Market Index Pool E	4.39K	0.06%	4.17K
Fidelity Series Total Market Index	5.23K	0.06%	-
Spartan Extended Market Index Pool F	4.93K	0.06%	-
Spartan Total Market Index Pool G	2.22K	0.03%	-
NT Ext Equity Mkt Idx Fd - L	1.93K	0.02%	-
Northern Trust Extended Eq Market Idx	1.93K	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Mar 25, 2024	Nijhawan Pardeep	Chief Executive Officer	Buy	$20.00K
Jan 10, 2023	van der Velden Peter	-	Sell	$367.39K
Jan 09, 2023	van der Velden Peter	-	Sell	$32.70K
Jan 10, 2023	van der Velden Peter	-	Sell	$33.97K
Jan 09, 2023	van der Velden Peter	-	Sell	$353.65K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-

EDSA Ownership FAQ

Who Owns Edesa Biotech?

Edesa Biotech shareholders are primarily institutional investors at 41.48%, followed by 17.06% insiders and 41.46% retail investors. The average institutional ownership in Edesa Biotech's industry, Biotech Stocks , is 382.11%, which Edesa Biotech falls below.

Who owns the most shares of Edesa Biotech?

Edesa Biotech’s largest shareholders are Velan capital investment management lp (687.5K shares, 9.79%), Stonepine capital management (687.5K shares, 9.79%), and Rubric capital management lp (687.5K shares, 9.74%). Together, they hold 29.32% of Edesa Biotech’s total shares outstanding.

Does Blackrock own Edesa Biotech?

BlackRock is not among the top 10 institutional shareholders of Edesa Biotech.

Who is Edesa Biotech’s biggest shareholder by percentage of total assets invested?

Velan capital investment management lp is Edesa Biotech’s biggest shareholder by percentage of total assets invested, with 1.59% of its assets in 687.5K Edesa Biotech shares, valued at 1.7M$.

Who is the top mutual fund holder of Edesa Biotech shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Edesa Biotech shares, with 0.44% of its total shares outstanding invested in 37.14K Edesa Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools